CD34 and acute myeloid leukemia: Using a H2O2-sensitive marker and a murine animal model, Huang et al. demonstrated that the closer AML blasts are located to endosteal niche (and further from the vascular niche) and have low ROS, the AML cell population is enriched in CD34+CD38- and enriched further following ARA-C treatment[85].